Document Detail


Demographics, diagnosis and treatment of 256 patients with tetrahydrobiopterin deficiency in mainland China: results of a retrospective, multicentre study.
MedLine Citation:
PMID:  23138986     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
BACKGROUND: National coverage of neonatal screening for hyperphenylalaninaemia (HPA) in China is still low and tests to differentiate causes of HPA are not performed in many centres. This study aimed to describe the demographics, geographic distribution, diagnosis, treatment and clinical outcomes of treatment, including intellectual development, in patients with tetrahydrobiopterin (BH(4)) deficiency in mainland China. METHODS: This was a retrospective, multicentre, chart review in patients with BH(4) deficiency across mainland China born 1985-2010. RESULTS: Two hundred fifty six patients were included; 59.9 % (267/446) of parents were from eastern China. Median (interquartile range) age at diagnosis decreased from 12.0 (5.5, 102.0) months to 2.0 (1.0, 3.5) months in patients born 1985-1999 (n = 28) and 2005-2010 (n = 152), respectively. 6-Pyruvoyl-tetrahydropterin synthase (PTPS) deficiency was the primary cause of BH(4) deficiency (96.0 %); four hotspot mutations accounted for 76.6 % of PTS gene mutations; two novel variants in the QDPR gene were identified. Most patients (83.6 %) received treatment with BH(4), L-dopa, 5-hydroxytryptophan and/or diet therapy. Target blood Phe concentration was confirmed at 88.9 % of visits; median (Q1, Q3) blood Phe concentration was 106.8 (73.0, 120.0) μmol/L during therapy and 117.0 (67.1, 120.0) μmol/L at last visit. Median (Q1, Q3) WISC IQ score was 80.0 (69.0, 90.0) in 33 patients. DQ scores were within normal range (≥85) for 37/59 (62.7 %) patients. Physical development indicators were within normal ranges. Treatment-related adverse events, reported in 20/256 (7.8 %) patients, were mild-to-moderate in severity. CONCLUSION: This study provides valuable information on the current and historical situation of BH(4) deficiency in mainland China.
Authors:
Jun Ye; Yanling Yang; Weimin Yu; Hui Zou; Jianhui Jiang; Rulai Yang; Sunny Shang; Xuefan Gu
Related Documents :
2663996 - Invasive streptococcal infections in the era before the acquired immune deficiency synd...
21739386 - The registry of canadian stroke network : an evolving methodology.
2667096 - Central nervous system complications in patients with bacteremia.
9195086 - Bacteremia due to klebsiella oxytoca: clinical features of patients and antimicrobial s...
18039016 - Eyebrow loss: clinical review.
24190876 - Predicting functional decline in older patients undergoing cardiac surgery.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-11-9
Journal Detail:
Title:  Journal of inherited metabolic disease     Volume:  -     ISSN:  1573-2665     ISO Abbreviation:  J. Inherit. Metab. Dis.     Publication Date:  2012 Nov 
Date Detail:
Created Date:  2012-11-9     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  7910918     Medline TA:  J Inherit Metab Dis     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Affiliation:
Xinhua Hospital affiliated to Shanghai JiaoTong University School of Medicine, Shanghai, People's Republic of China.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Chronic kidney disease in adolescent and adult patients with phenylketonuria.
Next Document:  Fumarylacetoacetate inhibits the initial step of the base excision repair pathway: implication for t...